Amryt Pharma Plc (AMYT) Return on Equity ROE from the fourth quarter 2021 to fourth quarter and annually, average high and low, overall ranking from Dec 31 2021 to - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Amryt Pharma Plc  (NASDAQ: AMYT)

Amryt Pharma Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Amryt Pharma Plc in the fourth quarter 2021?


Within the Major Pharmaceutical Preparations industry 82 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2021 from 0 to 3038.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2021)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Equity Change 439.24 % 170.54 % - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 0 0 0 0 0
Return On Equity (TTM) 0 % 0 % 0 % 0 % 0 %
AMYT's Total Ranking # 3038 # 0 # 0 # 0 #
Equity (TTM) in Millions 357 357 357 357 66
Seq. Equity Change 0 % 0 % 0 % 439.24 % -49.83 %
Seq. Net Income Change - - - - -

Back to AMYT Management Effectiveness >> AMYT's 5 Years Annual ROE >> Compare AMYT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 83
Sector # 244
Overall # 3038

Return On Equity Statistics
High Average Low
0.28 %
0.28 %
0.28 %
(Dec 31 2021)  





AMYT Annual Return On Equity (Dec 31 2021)
2021		 (Dec 31 2020)
2020


Total Equity in Millions 357 66 0 0 0
Y / Y Equity Change 439.24 % - - - -
Net Income in Millions 1 -105 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 0.28 % -158.03 % - - -

Back to AMYT Management Effectiveness >> AMYT's 5 Years Annual ROE >> Compare AMYT ROE to its Competitors




Annual Roe Comment
In 2021 ROE improved to 0.28 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
AMYT's' Return on Equity at Yahoo Finance
AMYT's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for AMYT's Competitors
Subscribers only: Roe for Amryt Pharma Plc's Suppliers
Subscribers only: Return On Equity for AMYT's Customers




Companies with similar Return On Equity at Dec 31 2021, within Healthcare Sector ROE

Date modified: 2023-03-22T13:18:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.